Original BioMedicals Has Signed a Contract with Company S to Develop a Sustained-Release Vitamin C+E Product
Important News
Our company has signed a contract with Company S, which focuses on the cross-strait medical aesthetics market. Through our nano-emulsion technology, we will assist Company S in developing a sustained-release vitamin C+E product. Subsequently, Original BioMedical will exclusively supply the core raw materials.
Prev
Original BioMedicals Has Signed a Tripartite Memorandum of Cooperation with Nanjing Xinbai Pharmaceutical Co., Ltd. and Jiangxi Rongchang Pharmaceutical Trade Co., Ltd. to Jointly Develop the Market for Iron Dextran Injection Products
Original BioMedicals Has Obtained a Japanese Invention Patent for its "Composition and Administration Method for Upper Respiratory Tract Drug Delivery."
